《大行報告》花旗:對吉利(00175.HK)展開30日正面催化劑觀察 評級「買入」
花旗發表評級報告指,吉利(00175.HK)推出Galaxy L7,其售價介乎13.87萬至17.37萬元人民幣,該行認為這個價格具吸引力,是主要針對比亞迪(01211.HK)宋PLUS DM-i。
該行預料,Galaxy L7車型月均銷售平穩,超過1.5萬輛,同時繼Galaxy L7之後,該行表示期待吉利未來推出Lynk08品牌。
該行指,對吉利展開30日正面催化劑觀察,並預料Galaxy L7於6、7及8月銷量分別達6,000輛、8,000輛及1萬輛,並給予其目標價為19.88元,維持其評級為「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.